Events

The World Science Conference in Israel (WSCI)  is a first of its kind gathering of academics and promising young talent from over 70 different countries including 15 Nobel laureates, Wolf Prize and Fields Medal winners, as well as  over 400 science students.  ElMindA has been invited to present at this unprecedented event and is excited to provide a great example of the Israeli spirit of innovation behind its cutting edge technology. 

 

World Science Conference Israel

World Science Conference Israel

The 2015 American Academy of Neurology Sports Concussion Conference  will take place July 24 through the 26 at the Colorado Convention Center in Denver, CO. The three day event will offer a one-of-a-kind opportunity for medical professionals to discover and discuss the very latest scientific advances in the world of sports concussion.

Don’t miss Adam Kiefer’s  presentation titled “Brain Network Activation as a Novel Biomarker for the Return to Play Pathway Following Sport-Related Brain Injury: A Prospective Case Study” during the AAN-SC  Poster Discussion Session
occurring Friday, July 24 from 3:45 pm to 4:00 pm in the Mile High Ballrooms 2-3 at the Colorado
Convention Center. Be sure to check out three additional posters featuring concussion management utilizing BNA in the Four Seasons Ballroom of the Colorado Convention Center.

Robert Kraft, New England Patriots Chairman and CEO, and 19 members of the U.S. Pro Football Hall of Fame learned firsthand about BNA during their recent trip to Israel in June 2015. Read more at The Times of Israel.

Robert Kraft meeting with Ronen Gadot, ElMindA CEO and Prof. Amir Geva, ElMindA Founder & CTO

BNATM technology and its potential utility in concussion assessment will be highlighted this week at the annual Big Sky Athletic Training and Sports Medicine Conference. Dr. Jeffrey Kutcher (University of Michigan) and Mike Palm (ATC, Athletico) will be giving a presentation titled “Brain Network Activation: A New Tool in Concussion assessment” on Monday February 2nd at 4:30PM MST. A poster titled “BNA in Concussion management,” authored by Dr. Kutcher and Amit Reches, PhD (ElMindA) will also be presented at the conference. ElMindA is a sponsor of  BSATSMC and will be showcasing its technology in the exhibitor hall.

 

 

ABF_8317 

Japanese Prime Minister, Shinzo Abe, led a delegation of top Japanese businessmen, representing the largest companies in Japan, through an Israeli innovation exhibition showcasing breakthrough Israeli technologies. ElMindA was one of only five companies selected to present to Abe, the Japanese delegation and Israeli Prime Minister, Benjamin Netanyahu.

Prime Minister Shinzo Abe had this to say about his interaction with the BNA™ technology; “We just experienced, along with Prime Minister Netanyahu, the truly ground breaking technologies and  innovations that Israel is so proud of… I was very interested in a device [BNA™ by ElMindA] that can really tell us how the brain functions. Maybe this new technology could tell us what and how people think. If Japan were to be the first country to develop and utilize this technology, then maybe in our next summit meeting with Prime Minister Netanyahu, Japan would have a competitive edge.”

 Watch PM Abe and Netanyahu at the Israeli Innovation Exhibition:

Watch PM Abe speaks about BNA™ Technology:

 

ElMindA has been chosen to showcase at The 2014 AIPAC conference in front of 14,000 people, taking place March 2nd-3rd 2014.

Read more on JNS report and in Israel21c.

Watch the innovation showcase presentation of CEO Ronen Gadot at AIPAC conference.

2014-03-02 16.22.04

Personalized Medicine World Conference (PMWC) International 2013, launched by Silicon Valley investors and entrepreneurs in 2009, provides a platform to foster collaboration, catalyze change and drive innovation in Personalized Medicine.  At this year’s conference, Eighteen emerging companies defining the next generation of platforms and technologies were pre-selected to compete towards the PMWC 2013 Israel Most Promising Company Award.  The top three companies were chosen by a first panel of VC Judges to present at the finals in which a second panel of Expert judges selected ElMindA to receive Israel’s Most Promising Company Award of 2013 handed by Dr. Ora Dar, Head of the Life Sciences Sector at the Office of the Chief Scientist of Israel.  “This is another vote of confidence for our great multidisciplinary team who are challenging one of the greatest unmet needs in medicine today – mapping the complex brain’s neuronal activity that underlies our daily function and behavior to create better diagnostics and treatments for brain disorders” said Ronen Gadot CEO of ElMindA.

PMWS

 

 

 

Recent results of the BNA technology in concussion management were presented by Prof. Anthony P. Kontos (University of Pittsburgh, UPMC Sports Concussion Program) as part of his presentation on “The Cutting Edge of Concussion Research: From the Lab to the Clinic”. A poster titled “Applying Brain Network Activation (BNA) Analysis to Sport-related Concussion: Preliminary Report” was also presented by UPMC at the conference.

Facing Tomorrow – the fifth Israeli Presidential Conference under the auspices of President Shimon Peres – took place in Jerusalem on 18-20 June, 2013.  As in previous years, the conference assembled world leaders, scholars, scientists, economists and business people to envision tomorrow and engage the central issues that will influence the face of our future. As the future of humankind is unequivocally linked to understanding the enigma of the human brain, a special Brain Science Experience Exhibition called “STATE OF MIND” was assembled at this year’s conference.

 

The STATE OF MIND exhibition was designed as a fascinating multimedia journey into the human brain, spotlighting scientific breakthroughs from the top brain researchers of Israel.  “We are proud and delighted that ElMindA’s Brain Activity Mapping technology, known as BNA™, was highlighted as the centerpiece of the STATE OF MIND exhibition,” said Professor Amir Geva of Ben Gurion University and the founder and CTO of ElMindA.

The ElMindA multimedia exhibit allowed participants, and President Peres himself, to experience first-hand a live demo of the BNA™ Brain Mapping Technology.

IMG_9685  DSC_1685DSC_1707 DSC_1718

 

 

The finalists will present in front of an international judging committee at BrainTech Israel 2013, Israel’s first brain technology conference, which will take place on October 14-15, 2013 in Tel Aviv.

For IBT official announcement click here.

 

ElMindA has been chosen to present at The Israeli Presidential Conference, Facing Tomorrow 2013, in a special brain exhibition: “Tomorrow state of Mind”, taking place  June 18th-20th  2013.

The Presidential Conference will assemble world leaders, international scholars, activists, poets and scientists, artists and clergy, entrepreneurs, economists and industrialists, as well as representatives of the next generation of leaders — promising young individuals who radiate innovation and creativity.

Israeli Presidential Conference, Facing Tomorrow 2013

copy210313-204

KBG_6409 A

 

One month after announcing plans for a landmark effort to better understand the workings of the brain, President Obama received a first-hand look at a groundbreaking brain mapping and imaging technology that may be critical to achieving this ambitious goal and to helping detect and manage a host of brain-related diseases and conditions.

 During a visit to the Israel National Museum with Prime Minister Netanyahu on Thursday, March 21, President Obama saw up-close six Israeli technology innovations as part of the “Israeli Technology for a Better World” exhibit hosted by Prime Minister Netanyahu. Among the technologies that were carefully selected by an expert panel to showcase Israel’s most transformational innovations was ElMindA’s Brain Network Activation or BNA™.

 Developed in association with researchers at Ben-Gurion University and the Technion Institute of Technology, the BNA™ advanced imaging technology applies sophisticated signal processing and pattern recognition algorithms to 3-dimensional electrophysiological data gathered by multi-sensor electroencephalography or EEG equipment.

“We are absolutely thrilled that ElMindA’s brain mapping technology was chosen for this one-of-a-kind exhibit involving President Obama and Prime Minister Netanyahu,” said ElMindA CEO Ronen Gadot, who demonstrated the technology to the world leaders. “It is particularly exciting given the President’s recent announcement of the Brain Mapping Project in his State of the Union Address   and the relevance of our technology in helping improve scientific understanding of the brain.”

“Such information can be vital to making progress against a host of diseases and conditions including Alzheimer’s disease, Parkinson’s and Traumatic Brain Injury (TBI) and to improving the health and well-being for hundreds of millions of people throughout the globe,” Gadot added.

 

Photo by: Kobi Gideon, GPO; Alex Kolomoisky

The poster: “Applying Brain Network Activation (BNA) Analysis to Sport-related Concussion: Preliminary Report” presented at the 2013 Big Sky Athletic Training Sports Medicine Conference.

 

ElMindA poster:  “A Novel Brain Imaging Technology for Concussion Management Demonstrated on Simulated and Drug induced Impairmant” presented at the Penn State Concussion In Sports Conference.

 

 

View our poster at the exhibition, ALKS 5461:

“A Novel Opioid Receptor Modulator, Normalizes Human EEG Responses in an Auditory Oddball Task after Cocaine Administration as Indicated by Brain Network Activation Analysis”

ElMindA poster: “A novel brain imaging technology for concussion management demonstrated on a scopolamine induced cognitive impairment model” presented at the 4th International Consensus Conference on Concussion in Sport

View our poster at the exhibit on Monday, October 15, 2012, from 1:00 PM to 5:00 PM

Keren Ziv to present in the 2012 ASCPT meeting

http://www.ascpt.org/Meetings/tabid/6416/Default.aspx

Back to top